Unlock the key to MedTech Development
Customized. Comprehensive. Strategic.
Learn More
Sometimes reimbursement can feel like a complicated puzzle. At JGS we strive to offer our clients complete solutions so that they spend their time focusing on what’s important…getting their device to market.

Our services include:

  • Customized Reimbursement Assessment
  • Customized Regulatory Assessment
  • Regulatory and Clinical Protocol Review
  • Strategic Reimbursement and Regulatory Planning
  • FDA Regulatory Submissions
  • HCPCS/CPT Code Applications
  • Reimbursement Call Center Services
  • Patient Assistance Programs
  • Payer Advocacy
  • Payment and Coverage Policy Review and Assessment
  • International Commercialization Program for MedTech and Life Science (ICP)



JGS designed an International Commercialization Program (ICP) for MedTech and Life Science companies to assist them with regulatory, reimbursement and commercialization for US market entry. We de-risk your investment by cutting costs and reducing time to market by providing a turnkey experience from concept through post-market launch. To learn more about the ICP please contact susan@jgsgroup.com.


Jen Murray CEO
Jennifer Murray, CEO
Jen has been at the forefront of the reimbursement industry for more than 23 years and is the founder of the JGS Group, Inc., a full-service reimbursement consulting group. Since 2001, JGS has provided reimbursement consulting for new and innovative technologies ranging from start-ups to Fortune 100 companies. Prior to launching the JGS Group, Jen held several positions at Covance. She has served as Covance’s representative for the National AIDS Advocacy Program, working directly with the Clinton administration on the Ryan White Fund, an initiative to secure alternative funding for AIDS/HIV patients. Jen has authored various articles on reimbursement-related issues in such publications as the FDANews, Medical Device and Diagnostics Manufacturer’s Magazine, and Drug Information Association News. She has spoken at conventions and workshops all over the world. She was appointed to the FDA News Advisory Panel in 2003 and is currently serving on the Board of Maryland Innovations Initiative (MII). Jen holds a Bachelor of Arts in Sociology and Psychology from Villanova University.

JGS Group

Jennifer Murray – President and CEO



JGS Group © 2020